With the highest attending rate of academics, TTOs and research institutions, BioFIT is the place where academia-industry collaborations get started. BioFIT has taken on a whole new dimension becoming the meeting point in Europe for tech transfer and for sourcing early-stage innovations stemming from public research institutions, academic spin-offs and emerging biotech companies. Together with big pharma, biotech and diagnostics companies, BioFIT operates as a platform to build partnerships for all public and private actors. BioFIT is also the marketplace for pre-seed, seed and Series A investment in Life Sciences.

>> SIGN UP NOW FOR BIOFIT 2018 AND SAVE UP TO €120: Register now!

>> LIMITED NUMBER OF STANDS: Contact us to book a booth!


A RECORD NUMBER OF MEETINGS AND ATTENDEES DURING BIOFIT 2017

1,200 

delegates

800 

organisations

30

countries represented

35+   

one-to-one meetings per participant

15

conferences & roundtable discussions

1,000+ 

deals generated

80 

speakers

100 

exhibitors


Why should you attend BioFIT?

Out of 1,000 BioFIT attendees, 1,000 deals have been generated.

The breakdown in terms of nature of deals is the following:

  • 35% of collaborative research projects
  • 30% of licensing deals
  • 15% of equity investment deals
  • 20% of services deals

Estimate based on the measurement of 2015 and 2016 delegates’ outcomes


Who will you meet?

by organisation

by function

TTOs / Research institutes / Academia 30%
Pharma / Diagnostics companies 20%
Biotech companies 20%
Preclinical CROs 15%
Investors 10%
Professional services & consulting 5%
CEO / VP / Managing Director 35%
Business Development 21%
R&D Researcher / Scientist 16%
Partnering / Licensing / Scouting / TTO 14%
Other 14%

What is inside BioFIT?